H. Lundbeck A/S (Lundbeck) ranked at the very top of a new global survey carried out among 600 patient groups from 56 different countries. With an overall first place, Lundbeck moved up from its number three ranking from a similar survey in 2011, placing ahead of Novartis and Gilead Science.
